StonvexLoading…
StonvexCore line items from POR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.56B | $3.48B | $2.91B | $2.64B |
Operating Income | $555.00M | $512.00M | $396.00M | $397.00M |
Net Income | $306.00M | $313.00M | $228.00M | $233.00M |
EPS (Diluted) | $2.77 | $3.01 | $2.33 | $2.60 |
Total Assets | $13.23B | $12.54B | $11.21B | $10.46B |
Total Liabilities | $9.10B | $8.75B | $7.89B | $7.68B |
Cash & Equivalents | $76.00M | $12.00M | $5.00M | $165.00M |
Free Cash Flow OCF − CapEx | $-71.00M | $-490.00M | $-938.00M | $-92.00M |
Shares Outstanding | 115.56M | 109.34M | 101.16M | 89.28M |